Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House panel chief demands accountability from US FDA on J&J plant bumbles

This article was originally published in Scrip

Executive Summary

Following through on his pledge to make the US FDA his main target for investigations and "hundreds" of hearings, Representative Darrel Issa (Republican-California), chairman of the US House Oversight and Government Reform Committee, again demanded accountability from the agency, this time for its failure to oversee a Puerto Rican plant at the center of numerous recalls of defective drugs made by Johnson & Johnson's McNeil Consumer Healthcare division.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC013044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel